Application Sponsors
ANDA 074075 | ACTAVIS MID ATLANTIC | |
Marketing Status
Application Products
001 | SYRUP;ORAL | EQ 0.5MG BASE/5ML | 0 | CLEMASTINE FUMARATE | CLEMASTINE FUMARATE |
FDA Submissions
| ORIG | 1 | AP | 1993-10-31 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2000-03-27 | |
LABELING; Labeling | SUPPL | 5 | AP | 2000-03-27 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 2000-03-27 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 2000-12-04 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 2000-12-04 | |
Submissions Property Types
SUPPL | 4 | Null | 0 |
SUPPL | 6 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
CDER Filings
ACTAVIS MID ATLANTIC
cder:Array
(
[0] => Array
(
[ApplNo] => 74075
[companyName] => ACTAVIS MID ATLANTIC
[docInserts] => ["",""]
[products] => [{"drugName":"CLEMASTINE FUMARATE","activeIngredients":"CLEMASTINE FUMARATE","strength":"EQ 0.5MG BASE\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CLEMASTINE FUMARATE","submission":"CLEMASTINE FUMARATE","actionType":"EQ 0.5MG BASE\/5ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)